Mayne Pharma Group Stock Filter Stocks by Fundamentals
MAYNF Stock | USD 3.10 0.10 3.33% |
Mayne Pharma Group fundamentals help investors to digest information that contributes to Mayne Pharma's financial success or failures. It also enables traders to predict the movement of Mayne Pink Sheet. The fundamental analysis module provides a way to measure Mayne Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Mayne Pharma pink sheet.
Mayne |
Did you try this?
Run AI Portfolio Architect Now
AI Portfolio ArchitectUse AI to generate optimal portfolios and find profitable investment opportunities |
All Next | Launch Module |
Mayne Fundamentals
Return On Equity | -0.41 | |||
Return On Asset | -0.0328 | |||
Profit Margin | (0.62) % | |||
Operating Margin | (0.17) % | |||
Current Valuation | 448.85 M | |||
Shares Outstanding | 1.74 B | |||
Shares Owned By Insiders | 22.62 % | |||
Shares Owned By Institutions | 18.64 % | |||
Price To Earning | 11.25 X | |||
Price To Book | 0.73 X | |||
Price To Sales | 0.65 X | |||
Revenue | 423.92 M | |||
Gross Profit | 171.03 M | |||
EBITDA | (104.64 M) | |||
Net Income | (263.34 M) | |||
Cash And Equivalents | 98.01 M | |||
Cash Per Share | 0.06 X | |||
Total Debt | 413.67 M | |||
Debt To Equity | 0.74 % | |||
Current Ratio | 0.84 X | |||
Book Value Per Share | 0.32 X | |||
Cash Flow From Operations | (7.21 M) | |||
Earnings Per Share | (0.03) X | |||
Number Of Employees | 31 | |||
Beta | 1.0 | |||
Market Capitalization | 235.41 M | |||
Total Asset | 1.29 B | |||
Annual Yield | 0.20 % | |||
Net Asset | 1.29 B |
About Mayne Pharma Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Mayne Pharma Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mayne Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mayne Pharma Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Mayne Pink Sheet
Mayne Pharma financial ratios help investors to determine whether Mayne Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Mayne with respect to the benefits of owning Mayne Pharma security.